Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccine value profile for Shigella
William P. Hausdorff, John Anderson, Karoun H. Bagamian, et al.
Vaccine (2023) Vol. 41, pp. S76-S94
Open Access | Times Cited: 11

Showing 11 citing articles:

Facilitating the development of urgently required combination vaccines
William P. Hausdorff, Shabir A. Madhi, Gagandeep Kang, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 6, pp. e1059-e1067
Open Access | Times Cited: 11
Vaccines and Monoclonal Antibodies as Alternative Strategies to Antibiotics to Fight Antimicrobial Resistance
Chiara La Guidara, Roberto Adamo, Claudia Sala, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5487-5487
Open Access | Times Cited: 7
Safety, Tolerability, and Immunogenicity of the InvaplexAR-Detox Shigella Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial
Geert V.T. Roozen, Nsofwa Sukwa, Masuzyo Chirwa, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 48-48
Open Access
A broad spectrum Shigella vaccine based on VirG53–353 multiepitope region produced in a cell-free system
Girmay Desalegn, Charlotte H. Abrahamson, K. Ross Turbyfill, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Potential impact and cost-effectiveness of Shigella vaccination in 102 low-income and middle-income countries in children aged 5 years or younger: a modelling study
John Anderson, Karoun H. Bagamian, Clint Pecenka, et al.
The Lancet Global Health (2023) Vol. 11, Iss. 6, pp. e880-e891
Open Access | Times Cited: 12
Reassessing potential economic value and health impact of effective Shigella vaccines
William P. Hausdorff, John Anderson, A. Louis Bourgeois, et al.
Bulletin of the World Health Organization (2024) Vol. 102, Iss. 1, pp. 65-74
Open Access | Times Cited: 3
IgG Serum Antibodies to Shigella sonnei Lipopolysaccharide Are Inversely Associated with the Incidence of Culture-Proven S. sonnei Shigellosis in Israeli Children and Adolescents
Valeria Asato, Ravit Bassal, Shiri Meron-Sudai, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 239-239
Open Access
Prioritizing Endemic Pathogens for Vaccine Research and Development by Capturing Regional and Country Stakeholder Values
Mateusz Hasso-Agopsowicz, Angela Hwang, Maria-Graciela Hollm-Delgado, et al.
(2024)
Closed Access
High-Throughput Luminescence-Based Serum Bactericidal Assay Optimization and Characterization to Assess Human Sera Functionality Against Multiple Shigella flexneri Serotypes
Valentina Caradonna, Martin Pinto, Renzo Alfini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11123-11123
Open Access
Whole genome sequencing and antimicrobial resistance among clinical isolates of Shigella sonnei in Addis Ababa, Ethiopia
Basha Ayele, Adane Mihret, Zeleke Mekonnen, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0313310-e0313310
Open Access
Synergistic efficacy of phage Henu10 with antibiotics against Shigella dysenteriae with insight into phage resistance and fitness trade-offs
Jing Zhao, Baohong Chen, W. Wang, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Page 1

Scroll to top